E-LIB Suche - Ergebnisse für: Groenland, Stefanie L.

1

Reasons for non-feasibility of therapeutic drug monitoring ..:

van der Kleij, Maud B. A. ; Guchelaar, Niels A. D. ; Meertens, Marinda...
British Journal of Cancer. 131 (2024) 5 - p. 843-851 , 2024

Link: https://doi.org/10.1038/..

2

Exposure–response analyses of BRAF- and MEK-inhibitors dabr..:

Groenland, Stefanie L. ; Janssen, J. M. ; Nijenhuis, C. M....
Cancer Chemotherapy and Pharmacology. 91 (2023) 6 - p. 447-456 , 2023

Link: https://doi.org/10.1007/..

3

Plasma concentration guided dosing of drugs used for the tr..:

van Dyk, Madelé ; Boylan, Chelsea ; Michelet, Robin...
BMJ Open. 12 (2022) 1 - p. e053308 , 2022

Link: https://doi.org/10.1136/..

4

Exposure–response analyses of cabozantinib in patients with..:

Krens, Stefanie D. ; van Erp, Nielka P. ; Groenland, Stefanie L....
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

5

Feasibility of therapeutic drug monitoring of sorafenib in ..:

Guchelaar, Niels A.D. ; van Eerden, Ruben A.G. ; Groenland, Stefanie L....
Biomedicine & Pharmacotherapy. 153 (2022) - p. 113393 , 2022

Link: https://doi.org/10.1016/..

6

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open La..:

Boosman, René J. ; de Gooijer, Cornedine J. ; Groenland, Stefanie L....
Pharmaceutical Research. 39 (2022) 4 - p. 669-676 , 2022

Link: https://doi.org/10.1007/..

7

Exposure–Response Analysis of Osimertinib in EGFR Mutation ..:

Boosman, René J. ; Jebbink, Merel ; Veldhuis, Wouter B....
Pharmaceutical Research. 39 (2022) 10 - p. 2507-2514 , 2022

Link: https://doi.org/10.1007/..

8

Developing a Nationwide Infrastructure for Therapeutic Drug..:

Mc Laughlin, Anna M. ; Schmulenson, Eduard ; Teplytska, Olga...
Cancers. 13 (2021) 24 - p. 6281 , 2021

Link: https://doi.org/10.3390/..

9

Effects of the Moderate CYP3A4 Inhibitor Erythromycin on th..:

Molenaar‐Kuijsten, Laura ; Braal, C. Louwrens ; Groenland, Stefanie L....
Clinical Pharmacology & Therapeutics. 111 (2021) 2 - p. 477-484 , 2021

Link: https://doi.org/10.1002/..

10

Response to "Optimized Alectinib Dose Regimen for Treatment..:

Groenland, Stefanie L. ; Geel, Dieuwertje R. ; Beijnen, Jos H....
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1164-1164 , 2021

Link: https://doi.org/10.1002/..

11

Correction to: Therapeutic drug monitoring of oral targeted..:

Mueller-Schoell, Anna ; Groenland, Stefanie L. ; Scherf-Clavel, Oliver...
European Journal of Clinical Pharmacology. 77 (2020) 4 - p. 465-465 , 2020

Link: https://doi.org/10.1007/..

12

Therapeutic drug monitoring of imatinib in patients with ga..:

IJzerman, Nikki S. ; Groenland, Stefanie L. ; Koenen, Anne Miek...
European Journal of Cancer. 136 (2020) - p. 140-148 , 2020

Link: https://doi.org/10.1016/..

13

Determination of the absolute bioavailability of oral imati..:

Roosendaal, Jeroen ; Groenland, Stefanie L. ; Rosing, Hilde...
European Journal of Clinical Pharmacology. 76 (2020) 8 - p. 1075-1082 , 2020

Link: https://doi.org/10.1007/..

14

Concomitant intake of abiraterone acetate and food to incre..:

Groenland, Stefanie L. ; van Nuland, Merel ; Bergman, Andries M....
European Journal of Cancer. 130 (2020) - p. 32-38 , 2020

Link: https://doi.org/10.1016/..

15

Cost-Neutral Optimization of Pazopanib Exposure by Splittin..:

The Dutch Pharmacology Oncology Group (DPOG) ; Groenland, Stefanie L. ; van Eerden, Ruben A. G....
Clinical Pharmacokinetics. 59 (2020) 7 - p. 941-948 , 2020

Link: https://doi.org/10.1007/..